Lymphir is part of the IL2 Receptor-Directed Cytotoxins class and treats Non-Hodgkin Lymphoma. IL2 Receptor-Directed Cytotoxins are used to treat to treat lymphoma. They work by targeting tumor cells that express the IL-2 receptor and delivering the cytotoxin directly to the cancer cells. Lymphir is only available as a brand name drug.